SEC Form 4 · accession 0001645627-17-000133
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 24, 2017
Accepted (ET)
Oct 27, 2017 · 4:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 24, 2017 | P | 3,000 | $0.0575 | A | 23,987,189 | D | |
| Common Stock | Oct 24, 2017 | P | 3,000 | $0.0579 | A | 23,990,189 | D | |
| Common Stock | Oct 24, 2017 | P | 3,000 | $0.055 | A | 23,993,189 | D | |
| Common Stock | Oct 24, 2017 | P | 2,910 | $0.0535 | A | 23,996,099 | D | |
| Common Stock | Oct 24, 2017 | P | 90 | $0.055 | A | 23,996,189 | D | |
| Common Stock | Oct 24, 2017 | P | 3,000 | $0.0571 | A | 23,999,189 | D | |
| Common Stock | Oct 25, 2017 | P | 3,000 | $0.056 | A | 24,002,189 | D | |
| Common Stock | Oct 25, 2017 | P | 3,000 | $0.056 | A | 24,005,189 | D | |
| Common Stock | Oct 25, 2017 | P | 3,000 | $0.0559 | A | 24,008,189 | D | |
| Common Stock | Oct 25, 2017 | P | 3,000 | $0.0567 | A | 24,011,189 | D | |
| Common Stock | Oct 26, 2017 | P | 3,000 | $0.057 | A | 24,014,189 | D | |
| Common Stock | Oct 26, 2017 | P | 2,000 | $0.0568 | A | 24,016,189 | D | |
| Common Stock | Oct 26, 2017 | P | 2,000 | $0.0568 | A | 24,018,189 | D | |
| Common Stock | Oct 26, 2017 | P | 2,000 | $0.0559 | A | 24,020,189 | D | |
| Common Stock | Oct 26, 2017 | P | 2,000 | $0.056 | A | 24,022,189 | D |
Table II — derivative securities
No Table II lines on this filing.